Global Uric Acid Drug Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Uric Acid Drug will have significant change from previous year. By the most conservative estimates of global Uric Acid Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Uric Acid Drug market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Uric Acid Drug market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Uric Acid Drug, covering the supply chain analysis, impact assessment to the Uric Acid Drug market size growth rate in several scenarios, and the measures to be undertaken by Uric Acid Drug companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Allopurinol
Febuxostat
Probenecid
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca plc
Boehringer Ingelheim GmbH
Regeneron Pharmaceuticals
GlaxoSmithKline plc
Teijin Pharma Ltd
Savient Pharmaceuticals
Merck & Co. Inc
Ironwood Pharmaceuticals
Novartis AG
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Uric Acid Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Uric Acid Drug market by identifying its various subsegments.
Focuses on the key global Uric Acid Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Uric Acid Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Uric Acid Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Uric Acid Drug?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Uric Acid Drug Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Uric Acid Drug Consumption 2015-2025
2.1.2 Uric Acid Drug Consumption CAGR by Region
2.2 Uric Acid Drug Segment by Type
2.2.1 Allopurinol
2.2.2 Febuxostat
2.2.3 Probenecid
2.3 Uric Acid Drug Consumption by Type
2.3.1 Global Uric Acid Drug Consumption Market Share by Type (2015-2020)
2.3.2 Global Uric Acid Drug Revenue and Market Share by Type (2015-2020)
2.3.3 Global Uric Acid Drug Sale Price by Type (2015-2020)
2.4 Uric Acid Drug Segment by Application
2.4.1 Online Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Hospital Pharmacies
2.5 Uric Acid Drug Consumption by Application
2.5.1 Global Uric Acid Drug Consumption Market Share by Type (2015-2020)
2.5.2 Global Uric Acid Drug Value and Market Share by Type (2015-2020)
2.5.3 Global Uric Acid Drug Sale Price by Type (2015-2020)
3 Global Uric Acid Drug by Company
3.1 Global Uric Acid Drug Sales Market Share by Company
3.1.1 Global Uric Acid Drug Sales by Company (2018-2020)
3.1.2 Global Uric Acid Drug Sales Market Share by Company (2018-2020)
3.2 Global Uric Acid Drug Revenue Market Share by Company
3.2.1 Global Uric Acid Drug Revenue by Company (2018-2020)
3.2.2 Global Uric Acid Drug Revenue Market Share by Company (2018-2020)
3.3 Global Uric Acid Drug Sale Price by Company
3.4 Global Uric Acid Drug Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Uric Acid Drug Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Uric Acid Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Uric Acid Drug by Regions
4.1 Uric Acid Drug by Regions
4.2 Americas Uric Acid Drug Consumption Growth
4.3 APAC Uric Acid Drug Consumption Growth
4.4 Europe Uric Acid Drug Consumption Growth
4.5 Middle East & Africa Uric Acid Drug Consumption Growth
5 Americas
5.1 Americas Uric Acid Drug Consumption by Countries
5.1.1 Americas Uric Acid Drug Consumption by Countries (2015-2020)
5.1.2 Americas Uric Acid Drug Value by Countries (2015-2020)
5.2 Americas Uric Acid Drug Consumption by Type
5.3 Americas Uric Acid Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Uric Acid Drug Consumption by Regions
6.1.1 APAC Uric Acid Drug Consumption by Regions (2015-2020)
6.1.2 APAC Uric Acid Drug Value by Regions (2015-2020)
6.2 APAC Uric Acid Drug Consumption by Type
6.3 APAC Uric Acid Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Uric Acid Drug by Countries
7.1.1 Europe Uric Acid Drug Consumption by Countries (2015-2020)
7.1.2 Europe Uric Acid Drug Value by Countries (2015-2020)
7.2 Europe Uric Acid Drug Consumption by Type
7.3 Europe Uric Acid Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Uric Acid Drug by Countries
8.1.1 Middle East & Africa Uric Acid Drug Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Uric Acid Drug Value by Countries (2015-2020)
8.2 Middle East & Africa Uric Acid Drug Consumption by Type
8.3 Middle East & Africa Uric Acid Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Uric Acid Drug Distributors
10.3 Uric Acid Drug Customer
11 Global Uric Acid Drug Market Forecast
11.1 Global Uric Acid Drug Consumption Forecast (2021-2025)
11.2 Global Uric Acid Drug Forecast by Regions
11.2.1 Global Uric Acid Drug Forecast by Regions (2021-2025)
11.2.2 Global Uric Acid Drug Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Uric Acid Drug Forecast by Type
11.8 Global Uric Acid Drug Forecast by Application
12 Key Players Analysis
12.1 AstraZeneca plc
12.1.1 Company Information
12.1.2 Uric Acid Drug Product Offered
12.1.3 AstraZeneca plc Uric Acid Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AstraZeneca plc Latest Developments
12.2 Boehringer Ingelheim GmbH
12.2.1 Company Information
12.2.2 Uric Acid Drug Product Offered
12.2.3 Boehringer Ingelheim GmbH Uric Acid Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Boehringer Ingelheim GmbH Latest Developments
12.3 Regeneron Pharmaceuticals
12.3.1 Company Information
12.3.2 Uric Acid Drug Product Offered
12.3.3 Regeneron Pharmaceuticals Uric Acid Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Regeneron Pharmaceuticals Latest Developments
12.4 GlaxoSmithKline plc
12.4.1 Company Information
12.4.2 Uric Acid Drug Product Offered
12.4.3 GlaxoSmithKline plc Uric Acid Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 GlaxoSmithKline plc Latest Developments
12.5 Teijin Pharma Ltd
12.5.1 Company Information
12.5.2 Uric Acid Drug Product Offered
12.5.3 Teijin Pharma Ltd Uric Acid Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Teijin Pharma Ltd Latest Developments
12.6 Savient Pharmaceuticals
12.6.1 Company Information
12.6.2 Uric Acid Drug Product Offered
12.6.3 Savient Pharmaceuticals Uric Acid Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Savient Pharmaceuticals Latest Developments
12.7 Merck & Co. Inc
12.7.1 Company Information
12.7.2 Uric Acid Drug Product Offered
12.7.3 Merck & Co. Inc Uric Acid Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Merck & Co. Inc Latest Developments
12.8 Ironwood Pharmaceuticals
12.8.1 Company Information
12.8.2 Uric Acid Drug Product Offered
12.8.3 Ironwood Pharmaceuticals Uric Acid Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Ironwood Pharmaceuticals Latest Developments
12.9 Novartis AG
12.9.1 Company Information
12.9.2 Uric Acid Drug Product Offered
12.9.3 Novartis AG Uric Acid Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Novartis AG Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Uric Acid Drug Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Uric Acid Drug Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Uric Acid Drug Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Allopurinol
Table 7. Major Players of Febuxostat
Table 8. Major Players of Probenecid
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Uric Acid Drug Consumption Market Share by Type (2015-2020)
Table 11. Global Uric Acid Drug Revenue by Type (2015-2020) ($ million)
Table 12. Global Uric Acid Drug Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Uric Acid Drug Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Uric Acid Drug Consumption Market Share by Application (2015-2020)
Table 16. Global Uric Acid Drug Value by Application (2015-2020)
Table 17. Global Uric Acid Drug Value Market Share by Application (2015-2020)
Table 18. Global Uric Acid Drug Sale Price by Application (2015-2020)
Table 19. Global Uric Acid Drug Sales by Company (2017-2019) (K Units)
Table 20. Global Uric Acid Drug Sales Market Share by Company (2017-2019)
Table 21. Global Uric Acid Drug Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Uric Acid Drug Revenue Market Share by Company (2017-2019)
Table 23. Global Uric Acid Drug Sale Price by Company (2017-2019)
Table 24. Global Uric Acid Drug Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Uric Acid Drug Products Offered
Table 26. Uric Acid Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Uric Acid Drug Consumption by Regions 2015-2020 (K Units)
Table 28. Global Uric Acid Drug Consumption Market Share by Regions 2015-2020
Table 29. Global Uric Acid Drug Value by Regions 2015-2020 ($ Millions)
Table 30. Global Uric Acid Drug Value Market Share by Regions 2015-2020
Table 31. Americas Uric Acid Drug Consumption by Countries (2015-2020) (K Units)
Table 32. Americas Uric Acid Drug Consumption Market Share by Countries (2015-2020)
Table 33. Americas Uric Acid Drug Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Uric Acid Drug Value Market Share by Countries (2015-2020)
Table 35. Americas Uric Acid Drug Consumption by Type (2015-2020) (K Units)
Table 36. Americas Uric Acid Drug Consumption Market Share by Type (2015-2020)
Table 37. Americas Uric Acid Drug Consumption by Application (2015-2020) (K Units)
Table 38. Americas Uric Acid Drug Consumption Market Share by Application (2015-2020)
Table 39. APAC Uric Acid Drug Consumption by Countries (2015-2020) (K Units)
Table 40. APAC Uric Acid Drug Consumption Market Share by Countries (2015-2020)
Table 41. APAC Uric Acid Drug Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Uric Acid Drug Value Market Share by Regions (2015-2020)
Table 43. APAC Uric Acid Drug Consumption by Type (2015-2020) (K Units)
Table 44. APAC Uric Acid Drug Consumption Market Share by Type (2015-2020)
Table 45. APAC Uric Acid Drug Consumption by Application (2015-2020) (K Units)
Table 46. APAC Uric Acid Drug Consumption Market Share by Application (2015-2020)
Table 47. Europe Uric Acid Drug Consumption by Countries (2015-2020) (K Units)
Table 48. Europe Uric Acid Drug Consumption Market Share by Countries (2015-2020)
Table 49. Europe Uric Acid Drug Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Uric Acid Drug Value Market Share by Countries (2015-2020)
Table 51. Europe Uric Acid Drug Consumption by Type (2015-2020) (K Units)
Table 52. Europe Uric Acid Drug Consumption Market Share by Type (2015-2020)
Table 53. Europe Uric Acid Drug Consumption by Application (2015-2020) (K Units)
Table 54. Europe Uric Acid Drug Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Uric Acid Drug Consumption by Countries (2015-2020) (K Units)
Table 56. Middle East & Africa Uric Acid Drug Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Uric Acid Drug Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Uric Acid Drug Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Uric Acid Drug Consumption by Type (2015-2020) (K Units)
Table 60. Middle East & Africa Uric Acid Drug Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Uric Acid Drug Consumption by Application (2015-2020) (K Units)
Table 62. Middle East & Africa Uric Acid Drug Consumption Market Share by Application (2015-2020)
Table 63. Uric Acid Drug Distributors List
Table 64. Uric Acid Drug Customer List
Table 65. Global Uric Acid Drug Consumption Forecast by Countries (2021-2025) (K Units)
Table 66. Global Uric Acid Drug Consumption Market Forecast by Regions
Table 67. Global Uric Acid Drug Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Uric Acid Drug Value Market Share Forecast by Regions
Table 69. Global Uric Acid Drug Consumption Forecast by Type (2021-2025) (K Units)
Table 70. Global Uric Acid Drug Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Uric Acid Drug Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Uric Acid Drug Value Market Share Forecast by Type (2021-2025)
Table 73. Global Uric Acid Drug Consumption Forecast by Application (2021-2025) (K Units)
Table 74. Global Uric Acid Drug Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Uric Acid Drug Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Uric Acid Drug Value Market Share Forecast by Application (2021-2025)
Table 77. AstraZeneca plc Product Offered
Table 78. AstraZeneca plc Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 79. AstraZeneca plc Main Business
Table 80. AstraZeneca plc Latest Developments
Table 81. AstraZeneca plc Basic Information, Company Total Revenue (in $ million), Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Boehringer Ingelheim GmbH Product Offered
Table 83. Boehringer Ingelheim GmbH Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 84. Boehringer Ingelheim GmbH Main Business
Table 85. Boehringer Ingelheim GmbH Latest Developments
Table 86. Boehringer Ingelheim GmbH Basic Information, Company Total Revenue (in $ million), Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Regeneron Pharmaceuticals Product Offered
Table 88. Regeneron Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 89. Regeneron Pharmaceuticals Main Business
Table 90. Regeneron Pharmaceuticals Latest Developments
Table 91. Regeneron Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. GlaxoSmithKline plc Product Offered
Table 93. GlaxoSmithKline plc Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 94. GlaxoSmithKline plc Main Business
Table 95. GlaxoSmithKline plc Latest Developments
Table 96. GlaxoSmithKline plc Basic Information, Company Total Revenue (in $ million), Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Teijin Pharma Ltd Product Offered
Table 98. Teijin Pharma Ltd Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 99. Teijin Pharma Ltd Main Business
Table 100. Teijin Pharma Ltd Latest Developments
Table 101. Teijin Pharma Ltd Basic Information, Company Total Revenue (in $ million), Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Savient Pharmaceuticals Product Offered
Table 103. Savient Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 104. Savient Pharmaceuticals Main Business
Table 105. Savient Pharmaceuticals Latest Developments
Table 106. Savient Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Merck & Co. Inc Product Offered
Table 108. Merck & Co. Inc Basic Information, Company Total Revenue (in $ million), Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Merck & Co. Inc Main Business
Table 110. Merck & Co. Inc Latest Developments
Table 111. Merck & Co. Inc Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 112. Ironwood Pharmaceuticals Product Offered
Table 113. Ironwood Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 114. Ironwood Pharmaceuticals Main Business
Table 115. Ironwood Pharmaceuticals Latest Developments
Table 116. Ironwood Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Novartis AG Product Offered
Table 118. Novartis AG Uric Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 119. Novartis AG Main Business
Table 120. Novartis AG Latest Developments
Table 121. Novartis AG Basic Information, Company Total Revenue (in $ million), Uric Acid Drug Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Uric Acid Drug
Figure 2. Uric Acid Drug Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Uric Acid Drug Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Uric Acid Drug Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Allopurinol
Figure 7. Product Picture of Febuxostat
Figure 8. Product Picture of Probenecid
Figure 9. Global Uric Acid Drug Consumption Market Share by Type (2015-2020)
Figure 10. Global Uric Acid Drug Value Market Share by Type (2015-2020)
Figure 11. Uric Acid Drug Consumed in Online Pharmacies
Figure 12. Global Uric Acid Drug Market: Online Pharmacies (2015-2020) (K Units)
Figure 13. Global Uric Acid Drug Market: Online Pharmacies (2015-2020) ($ Millions)
Figure 14. Uric Acid Drug Consumed in Retail Pharmacies
Figure 15. Global Uric Acid Drug Market: Retail Pharmacies (2015-2020) (K Units)
Figure 16. Global Uric Acid Drug Market: Retail Pharmacies (2015-2020) ($ Millions)
Figure 17. Uric Acid Drug Consumed in Hospital Pharmacies
Figure 18. Global Uric Acid Drug Market: Hospital Pharmacies (2015-2020) (K Units)
Figure 19. Global Uric Acid Drug Market: Hospital Pharmacies (2015-2020) ($ Millions)
Figure 20. Global Uric Acid Drug Consumption Market Share by Application (2015-2020)
Figure 21. Global Uric Acid Drug Value Market Share by Application (2015-2020)
Figure 22. Global Uric Acid Drug Sales Market Share by Company in 2017
Figure 23. Global Uric Acid Drug Sales Market Share by Company in 2019
Figure 24. Global Uric Acid Drug Revenue Market Share by Company in 2017
Figure 25. Global Uric Acid Drug Revenue Market Share by Company in 2019
Figure 26. Global Uric Acid Drug Sale Price by Company in 2019
Figure 27. Global Uric Acid Drug Consumption Market Share by Regions 2015-2020
Figure 28. Global Uric Acid Drug Value Market Share by Regions 2015-2020
Figure 29. Americas Uric Acid Drug Consumption 2015-2020 (K Units)
Figure 30. Americas Uric Acid Drug Value 2015-2020 ($ Millions)
Figure 31. APAC Uric Acid Drug Consumption 2015-2020 (K Units)
Figure 32. APAC Uric Acid Drug Value 2015-2020 ($ Millions)
Figure 33. Europe Uric Acid Drug Consumption 2015-2020 (K Units)
Figure 34. Europe Uric Acid Drug Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Uric Acid Drug Consumption 2015-2020 (K Units)
Figure 36. Middle East & Africa Uric Acid Drug Value 2015-2020 ($ Millions)
Figure 37. Americas Uric Acid Drug Consumption Market Share by Countries in 2019
Figure 38. Americas Uric Acid Drug Value Market Share by Countries in 2019
Figure 39. Americas Uric Acid Drug Consumption Market Share by Type in 2019
Figure 40. Americas Uric Acid Drug Consumption Market Share by Application in 2019
Figure 41. United States Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 42. United States Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 44. Canada Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 46. Mexico Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Uric Acid Drug Consumption Market Share by Countries in 2019
Figure 48. APAC Uric Acid Drug Value Market Share by Regions in 2019
Figure 49. APAC Uric Acid Drug Consumption Market Share by Type in 2019
Figure 50. APAC Uric Acid Drug Consumption Market Share by Application in 2019
Figure 51. China Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 52. China Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 54. Japan Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 56. Korea Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 58. Southeast Asia Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 59. India Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 60. India Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 62. Australia Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Uric Acid Drug Consumption Market Share by Countries in 2019
Figure 64. Europe Uric Acid Drug Value Market Share by Countries in 2019
Figure 65. Europe Uric Acid Drug Consumption Market Share by Type in 2019
Figure 66. Europe Uric Acid Drug Consumption Market Share by Application in 2019
Figure 67. Germany Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 68. Germany Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 69. France Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 70. France Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 71. UK Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 72. UK Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 74. Italy Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 76. Russia Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Uric Acid Drug Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Uric Acid Drug Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Uric Acid Drug Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Uric Acid Drug Consumption Market Share by Application in 2019
Figure 81. Egypt Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 82. Egypt Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 84. South Africa Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 86. Israel Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 88. Turkey Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Uric Acid Drug Consumption Growth 2015-2020 (K Units)
Figure 90. GCC Countries Uric Acid Drug Value Growth 2015-2020 ($ Millions)
Figure 91. Global Uric Acid Drug Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 92. Global Uric Acid Drug Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 94. Americas Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 95. APAC Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 96. APAC Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 97. Europe Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 98. Europe Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 100. Middle East & Africa Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 101. United States Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 102. United States Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 103. Canada Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 104. Canada Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 105. Mexico Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 106. Mexico Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 107. Brazil Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 108. Brazil Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 109. China Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 110. China Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 111. Japan Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 112. Japan Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 113. Korea Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 114. Korea Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 116. Southeast Asia Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 117. India Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 118. India Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 119. Australia Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 120. Australia Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 121. Germany Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 122. Germany Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 123. France Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 124. France Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 125. UK Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 126. UK Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 127. Italy Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 128. Italy Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 129. Russia Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 130. Russia Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 131. Spain Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 132. Spain Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 133. Egypt Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 134. Egypt Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 135. South Africa Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 136. South Africa Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 137. Israel Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 138. Israel Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 139. Turkey Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 140. Turkey Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Uric Acid Drug Consumption 2021-2025 (K Units)
Figure 142. GCC Countries Uric Acid Drug Value 2021-2025 ($ Millions)
Figure 143. AstraZeneca plc Uric Acid Drug Market Share (2018-2020)
Figure 144. Boehringer Ingelheim GmbH Uric Acid Drug Market Share (2018-2020)
Figure 145. Regeneron Pharmaceuticals Uric Acid Drug Market Share (2018-2020)
Figure 146. GlaxoSmithKline plc Uric Acid Drug Market Share (2018-2020)
Figure 147. Teijin Pharma Ltd Uric Acid Drug Market Share (2018-2020)
Figure 148. Savient Pharmaceuticals Uric Acid Drug Market Share (2018-2020)
Figure 149. Merck & Co. Inc Uric Acid Drug Market Share (2018-2020)
Figure 150. Ironwood Pharmaceuticals Uric Acid Drug Market Share (2018-2020)
Figure 151. Novartis AG Uric Acid Drug Market Share (2018-2020)
